Eisai Trial Site 1

Kyoto, Kyoto 602-8566

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease — Completed
• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease — Stopped early